Login/Sign Up
Calcigan 0.25 mcg Softgel Capsule 10's
Calcigan 0.25 mcg Softgel Capsule is used to treat low blood calcium levels. It contains Calcitriol, which raises Vitamin D levels and thereby increases calcium levels in the blood. In some cases, this medicine may cause side effects such as stomach upset, nausea, vomiting, loss of appetite, mood changes, weakness, tiredness, and headache. Inform the doctor if you are pregnant or breastfeeding, taking any other medication, or have any pre-existing medical conditions.
₹113.4*
MRP ₹126
10% off
₹107.1*
MRP ₹126
15% CB
₹18.9 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Calcigan 0.25 mcg Softgel Capsule belongs to a group of medicines called 'vitamin D metabolites' primarily used to treat low blood calcium levels. Calcigan 0.25 mcg Softgel Capsule effectively treats various conditions caused by low calcium levels in the body, such as osteoporosis (weak and brittle bones), osteomalacia/rickets (weak bones), hypoparathyroidism (low levels of parathyroid hormone), and latent tetany (a muscle disease with low blood calcium levels). Calcigan 0.25 mcg Softgel Capsule can also be given to pregnant, nursing, and postmenopausal women to ensure that they are getting enough calcium. Additionally, Calcigan 0.25 mcg Softgel Capsule is used to treat hyperparathyroidism (overactive parathyroid glands) and metabolic bone disease in people with chronic kidney disease, surgery, or other conditions.
Calcigan 0.25 mcg Softgel Capsule contains Calcitriol (Vitamin D3); it is used to prevent or treat a calcium deficiency. It is an essential nutrient to maintain bone formation and maintenance. Calcitriol is a synthetic version of Vitamin D3 and treats calcium deficiency with hypoparathyroidism (the parathyroid gland's decreased activity) and metabolic bone diseases in people with chronic kidney failure. It raises Vitamin D levels and thereby increases calcium levels in the blood. This helps in improving the absorption rate of calcium from the intestine.
Take Calcigan 0.25 mcg Softgel Capsule as prescribed by your doctor. Depending on your medical condition, you are advised to take Calcigan 0.25 mcg Softgel Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, Calcigan 0.25 mcg Softgel Capsule can cause side effects like constipation, stomach upset, nausea, vomiting, loss of appetite, mood changes, weakness, tiredness, fast or pounding heartbeat, bone/muscle pain, and headache. Most of these side effects of Calcigan 0.25 mcg Softgel Capsule do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
If you are known to be allergic to Calcigan 0.25 mcg Softgel Capsule or its inactive components, please inform your doctor. Pregnant or breastfeeding women should consult their doctor before taking Calcigan 0.25 mcg Softgel Capsule . Higher doses of Vitamin D than the recommended daily dose should be used in pregnant women only when advised by the doctor. Calcigan 0.25 mcg Softgel Capsule may pass into the breast milk. Hence, breastfeeding mothers need to seek medical advice before starting Calcigan 0.25 mcg Softgel Capsule . Do not take Calcigan 0.25 mcg Softgel Capsule if you have hypercalcemia (high calcium levels), hypervitaminosis D (high vitamin D levels), and malabsorption syndrome (difficulty absorbing nutrition from food). Inform your doctor if you have any heart/kidney/liver/blood vessel diseases, kidney stones, sarcoidosis (growth of inflammatory cells in different parts of the body), Crohn's disease (inflammatory bowel disease), Whipple's disease (bacterial infection affecting joints and digestive system), achlorhydria (little or no stomach acid), low levels of bile, and phosphate imbalance.
Calcigan 0.25 mcg Softgel Capsule effectively treats various conditions caused by low calcium levels in the body, such as osteoporosis (weak and brittle bones), osteomalacia/rickets (weak bones), hypoparathyroidism (low levels of parathyroid hormone), and latent tetany (a muscle disease with low blood calcium levels). Calcigan 0.25 mcg Softgel Capsule can also be given to pregnant, nursing, and postmenopausal women to ensure that they are getting enough calcium. Additionally, Calcigan 0.25 mcg Softgel Capsule is used to treat hyperparathyroidism (overactive parathyroid glands) and metabolic bone disease in people with chronic kidney disease, surgery, or other conditions.
Before taking Calcigan 0.25 mcg Softgel Capsule , inform your doctor if you are undergoing hemodialysis due to kidney problems and have a stent in the heart. Calcigan 0.25 mcg Softgel Capsule may alter calcium levels, so it is recommended to monitor calcium levels in the blood and urine regularly. Inform your doctor immediately if you notice fever, increased thirst and urination, dehydration, bedwetting, constipation, and stomach pain, as they may sign very high calcium levels in your blood. Pregnant or breastfeeding women should consult their doctor before taking Calcigan 0.25 mcg Softgel Capsule . Higher doses of Vitamin D than the recommended daily dose should be used in pregnant women only when advised by the doctor. Calcigan 0.25 mcg Softgel Capsule may pass into the breast milk. Hence, breastfeeding mothers need to seek medical advice before starting Calcigan 0.25 mcg Softgel Capsule . Do not take Calcigan 0.25 mcg Softgel Capsule if you have hypercalcemia (high calcium levels), hypervitaminosis D (high vitamin D levels), and malabsorption syndrome (difficulty absorbing nutrition from food).
Drug-Drug interactions: Calcigan 0.25 mcg Softgel Capsule may interact with other medicines containing vitamin D, Steroid medicines (hydrocortisone, prednisolone, dexamethasone), a medicine used to treat high levels of cholesterol in your blood (cholestyramine), medications containing magnesium, such as antacids (used to treat indigestion), medicines used to treat heart disease (digoxin or digitoxin), and diuretic medicines (bendroflumethiazide, chlortalidone, indapamide)
Drug-Food interactions: Do not take foods enriched with vitamin D and avoid a high intake of dairy products such as milk, ghee, and cheese.
Drug-Disease interactions: Calcigan 0.25 mcg Softgel Capsule is not recommended for use in patients with bleeding disorders, hypercalcemia (high levels of calcium in the blood), metastatic calcification (extra deposits of calcium in the body), kidney problems, high blood pressure, cancer, optic nerve damage, and high levels of vitamin D.
Osteoporosis: Osteoporosis is a bone disease that weakens and brittle bones by decreasing bone density. As bones become less dense, they weaken and are more likely to break. Breaking a bone is a serious complication of osteoporosis, especially in older patients. Women are much more likely to develop osteoporosis than are men. Signs and symptoms include back pain caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone that breaks much more quickly than expected.
Osteomalacia/Rickets: A bone disease caused by softening and weakening bones in children due to inadequate vitamin D. Adults can experience a similar condition known as osteomalacia. It causes bone pain, poor growth, and soft, weak bones that can lead to bone deformities.
Tetany: A disease condition due to low calcium levels (hypocalcemia) in the body causes cramps and spasms in the hands, feet, and larynx (voice box).
Alcohol
Caution
Drinking alcohol can affect calcium absorption; hence, it is advised to limit the alcohol intake while using Calcigan 0.25 mcg Softgel Capsule .
Pregnancy
Caution
Use higher doses of Calcigan 0.25 mcg Softgel Capsule during pregnancy than the daily dietary allowance only when the doctor advises. Calcitriol in higher doses may harm the fetus. Your doctor will weigh the potential risks and benefits before prescribing Calcigan 0.25 mcg Softgel Capsule .
Breast Feeding
Caution
Consult your doctor before taking Calcigan 0.25 mcg Softgel Capsule if you are breastfeeding. Calcigan 0.25 mcg Softgel Capsule can pass into the breast milk. If Calcigan 0.25 mcg Softgel Capsule is used during breastfeeding, please monitor the mother and the infant's serum calcium levels.
Driving
Safe if prescribed
Calcigan 0.25 mcg Softgel Capsule may not affect your ability to drive.
Liver
Caution
Before taking $ name, let your doctor know if you have any history of liver disease. Hepatic impairment/liver disease can alter the metabolic and therapeutic activity of certain Vitamin D forms.
Kidney
Caution
It is advised to seek a doctor's advice before starting Calcigan 0.25 mcg Softgel Capsule if you have kidney diseases like kidney stones or are undergoing dialysis. Calcitriol in Calcigan 0.25 mcg Softgel Capsule increases inorganic phosphate levels in serum; hence, caution should be taken in patients undergoing dialysis to maintain adequate phosphorus levels and avoid ectopic calcification (calcium deposition).
Children
Caution
Calcigan 0.25 mcg Softgel Capsule should be used with caution in children and only if prescribed by a doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes